Che-Jui Lee

7PUBLICATIONS
21CO-AUTHORS
Solid tumoursMolecular targetsLiquid biopsiesGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 28, 2022
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.

Che-Jui Lee, Elodie Modave, Bram Boeckx

|Apr 23, 2022
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma.

Britt Van Renterghem, Agnieszka Wozniak, Ludovica Tarantola

|Dec 10, 2021
Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial.

Che-Jui Lee, Elodie Modave, Bram Boeckx

|Sep 23, 2021
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.

Che-Jui Lee, Patrick Schöffski, Elodie Modave

|Aug 27, 2021
Systemic Investigation Identifying Salivary miR-196b as a Promising Biomarker for Early Detection of Head-Neck Cancer and Oral Precancer Lesions.

Ann-Joy Cheng, Guo-Rung You, Che-Jui Lee

|Aug 20, 2021
Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research.

Che-Jui Lee, Agnieszka Wozniak, Thomas Van Cann

Pageof 2

Frequent Collaborators

6 joint publications

Patrick Schöffski

4 joint publications

Agnieszka Wozniak

4 joint publications

Raf Sciot

3 joint publications

Judith V M G Bovée